Skip to main content
Top
Published in: European Archives of Oto-Rhino-Laryngology 3/2017

01-03-2017 | Review Article

Is gentamycin delivery via sustained-release vehicles a safe and effective treatment for refractory Meniere’s disease? A critical analysis of published interventional studies

Authors: Petros V. Vlastarakos, Emily Iacovou, Thomas P. Nikolopoulos

Published in: European Archives of Oto-Rhino-Laryngology | Issue 3/2017

Login to get access

Abstract

The aim of this study is to review the literature on sustained-release vehicles delivering gentamycin in the inner ear of patients suffering from Meniere’s disease (MD), and critically assess their respective clinical effectiveness and safety. A systematic literature review was conducted in Medline and other database sources until January 2016, along with critical analysis of pooled data. Overall, six prospective and four retrospective studies were systematically analyzed. The total number of treated patients was 320. A 2 year patient follow up was only reported in 40 % of studies. Inner ear gentamycin delivery using sustained-release vehicles is associated with improved vertigo control (strength of recommendation B), and quality of life (strength of recommendation B) in MD sufferers. In addition, dynamic-release devices seem to achieve high rates of improvement in the appearance of tinnitus (65.4 %) and aural pressure (76.2 %). By contrast, percentages of complete and partial hearing loss appear unacceptably high (31.08 and 23.38 % of patients, respectively), compared to historical data involving simple intratympanic gentamycin injections. Sustained-release vehicles for gentamycin delivery may have a role in the management of MD patients who have previously failed intratympanic gentamycin injections, or those who have already lost serviceable hearing. Their use as first line treatment over single intratympanic injections for all MD patients, who do not respond to conservative treatment should be discouraged.
Literature
1.
go back to reference Vassiliou A, Vlastarakos PV, Maragoudakis P, Candiloros D, Nikolopoulos TP (2011) Meniere’s disease: still a mystery disease with difficult differential diagnosis. Ann Indian Acad Neurol 14(1):12–18CrossRefPubMedPubMedCentral Vassiliou A, Vlastarakos PV, Maragoudakis P, Candiloros D, Nikolopoulos TP (2011) Meniere’s disease: still a mystery disease with difficult differential diagnosis. Ann Indian Acad Neurol 14(1):12–18CrossRefPubMedPubMedCentral
2.
go back to reference Cunha F, Settanni FA, Ganança FF (2005) What is the effect of dizziness on the quality of life for patients with Meniere’s disease? Rev Laryngol Otol Rhinol (Bord). 126(3):155–158PubMed Cunha F, Settanni FA, Ganança FF (2005) What is the effect of dizziness on the quality of life for patients with Meniere’s disease? Rev Laryngol Otol Rhinol (Bord). 126(3):155–158PubMed
3.
go back to reference Anderson JP, Harris JP (2001) Impact of Meniere’s disease on quality of life. Otol Neurotol. 22(6):888–894CrossRefPubMed Anderson JP, Harris JP (2001) Impact of Meniere’s disease on quality of life. Otol Neurotol. 22(6):888–894CrossRefPubMed
4.
go back to reference Soderman AC, Bagger–Sjoback D, Bergenius J, Langius A (2002) Factors influencing quality of life in patients with Meniere’s disease, identified by a multidimensional approach. Otol Neurotol. 23(6):941–948CrossRefPubMed Soderman AC, Bagger–Sjoback D, Bergenius J, Langius A (2002) Factors influencing quality of life in patients with Meniere’s disease, identified by a multidimensional approach. Otol Neurotol. 23(6):941–948CrossRefPubMed
5.
go back to reference Pullens B, van Benthem PP (2011) Intratympanic gentamicin for Ménière’s disease or syndrome. Cochrane Database Syst Rev.16:CD008234 Pullens B, van Benthem PP (2011) Intratympanic gentamicin for Ménière’s disease or syndrome. Cochrane Database Syst Rev.16:CD008234
6.
go back to reference Chia SH, Gamst AC, Anderson JP, Harris JP (2004) Intratympanic gentamycin therapy for Ménière’s disease: a meta-analysis. Otol Neurotol. 25:544–552CrossRefPubMed Chia SH, Gamst AC, Anderson JP, Harris JP (2004) Intratympanic gentamycin therapy for Ménière’s disease: a meta-analysis. Otol Neurotol. 25:544–552CrossRefPubMed
7.
go back to reference Cohen-Kerem R, Kisilevsky V, Einarson TR et al (2004) Intratympanic gentamicin for Menière’s disease: a meta-analysis. Laryngoscope. 114:2085–2091CrossRefPubMed Cohen-Kerem R, Kisilevsky V, Einarson TR et al (2004) Intratympanic gentamicin for Menière’s disease: a meta-analysis. Laryngoscope. 114:2085–2091CrossRefPubMed
8.
go back to reference Diamond C, O’Connell DA, Hornig JD et al (2003) Systematic review of intratympanic gentamicin in Meniere’s disease. J Otolaryngol 32:351–361CrossRefPubMed Diamond C, O’Connell DA, Hornig JD et al (2003) Systematic review of intratympanic gentamicin in Meniere’s disease. J Otolaryngol 32:351–361CrossRefPubMed
9.
go back to reference Huon LK, Fang TY, Wang PC (2012) Outcomes of intratympanic gentamicin injection to treat Ménière’s disease. Otol Neurotol. 33(5):706–714CrossRefPubMed Huon LK, Fang TY, Wang PC (2012) Outcomes of intratympanic gentamicin injection to treat Ménière’s disease. Otol Neurotol. 33(5):706–714CrossRefPubMed
10.
go back to reference Yoshioka M, Naganawa S, Sone M, Nakata S, Teranishi M, Nakashima T (2009) Individual differences in the permeability of the round window: evaluating the movement of intratympanic gadolinium into the inner ear. Otol Neurotol. 30:645–648CrossRefPubMed Yoshioka M, Naganawa S, Sone M, Nakata S, Teranishi M, Nakashima T (2009) Individual differences in the permeability of the round window: evaluating the movement of intratympanic gadolinium into the inner ear. Otol Neurotol. 30:645–648CrossRefPubMed
11.
go back to reference Silverstein H, Rowan PT, Olds MJ, Rosenberg SI (1997) Inner ear perfusion and the role of round window patency. Am J Otol 18:586–589PubMed Silverstein H, Rowan PT, Olds MJ, Rosenberg SI (1997) Inner ear perfusion and the role of round window patency. Am J Otol 18:586–589PubMed
12.
go back to reference Alzamil KS, Linthicum FH Jr (2000) Extraneous round window membranes and plugs: possible effect on intratympanic therapy. Ann Otol Rhinol Laryngol. 109:30–32CrossRefPubMed Alzamil KS, Linthicum FH Jr (2000) Extraneous round window membranes and plugs: possible effect on intratympanic therapy. Ann Otol Rhinol Laryngol. 109:30–32CrossRefPubMed
13.
go back to reference Nakashima T, Nananawa S, Sone M, Teranishi M, Kawauchi H (2010) Round window surgery. Otol Neurotol. 31:549–550 (author reply 550. Comment on Middle ear exploration in patients with Ménière’s disease who have failed outpatient intratympanic gentamicin therapy) CrossRefPubMed Nakashima T, Nananawa S, Sone M, Teranishi M, Kawauchi H (2010) Round window surgery. Otol Neurotol. 31:549–550 (author reply 550. Comment on Middle ear exploration in patients with Ménière’s disease who have failed outpatient intratympanic gentamicin therapy) CrossRefPubMed
14.
go back to reference Thomsen J, Charabi S, Tos M (2000) Preliminary results of a new delivery system for gentamicin to the inner ear in patients with Meniere’s disease. Eur Arch Otorhinolaryngol 257(7):362–365CrossRefPubMed Thomsen J, Charabi S, Tos M (2000) Preliminary results of a new delivery system for gentamicin to the inner ear in patients with Meniere’s disease. Eur Arch Otorhinolaryngol 257(7):362–365CrossRefPubMed
16.
go back to reference Hoffer ME, Allen K, Kopke RD et al (2001) Transtympanic versus sustained-release administration of gentamicin: kinetics, morphology, and function. Laryngoscope 111:1343–1357CrossRefPubMed Hoffer ME, Allen K, Kopke RD et al (2001) Transtympanic versus sustained-release administration of gentamicin: kinetics, morphology, and function. Laryngoscope 111:1343–1357CrossRefPubMed
17.
go back to reference Rah YC, Han JJ, Park J, Choi BY, Koo JW (2015) Management of intractable Ménière’s disease after intratympanic injection of gentamicin. Laryngoscope 125(4):972–978CrossRefPubMed Rah YC, Han JJ, Park J, Choi BY, Koo JW (2015) Management of intractable Ménière’s disease after intratympanic injection of gentamicin. Laryngoscope 125(4):972–978CrossRefPubMed
18.
go back to reference MacKeith SA, Whiteside OJ, Mawby T, Bottrill ID (2014) Middle ear gentamicin-soaked pledgets in the treatment of Ménière’s disease. Otol Neurotol 35(2):305–309CrossRefPubMed MacKeith SA, Whiteside OJ, Mawby T, Bottrill ID (2014) Middle ear gentamicin-soaked pledgets in the treatment of Ménière’s disease. Otol Neurotol 35(2):305–309CrossRefPubMed
19.
go back to reference Crane BT, Minor LB, Della Santina CC, Carey JP (2009) Middle ear exploration in patients with Ménière’s disease who have failed outpatient intratympanic gentamicin therapy. Otol Neurotol 30:619–624CrossRefPubMed Crane BT, Minor LB, Della Santina CC, Carey JP (2009) Middle ear exploration in patients with Ménière’s disease who have failed outpatient intratympanic gentamicin therapy. Otol Neurotol 30:619–624CrossRefPubMed
20.
go back to reference Suryanarayanan R, Srinivasan VR, O’Sullivan G (2009) Transtympanic gentamicin treatment using Silverstein MicroWick in Meniere’s disease patients: long term outcome. J Laryngol Otol 123:45–49CrossRefPubMed Suryanarayanan R, Srinivasan VR, O’Sullivan G (2009) Transtympanic gentamicin treatment using Silverstein MicroWick in Meniere’s disease patients: long term outcome. J Laryngol Otol 123:45–49CrossRefPubMed
21.
go back to reference Hill SL, Digges EN, Silverstein H (2006) Long-term follow-up after gentamicin application via the Silverstein MicroWick in the treatment of Ménière’s disease. Ear Nose Throat J 85(8):494, 496, 498 Hill SL, Digges EN, Silverstein H (2006) Long-term follow-up after gentamicin application via the Silverstein MicroWick in the treatment of Ménière’s disease. Ear Nose Throat J 85(8):494, 496, 498
22.
go back to reference Casani A, Nuti D, Franceschini SS, Gaudini E, Dallan I (2005) Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Ménière’s disease: effects on vestibular function. Otolaryngol Head Neck Surg 133:929–935CrossRefPubMed Casani A, Nuti D, Franceschini SS, Gaudini E, Dallan I (2005) Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Ménière’s disease: effects on vestibular function. Otolaryngol Head Neck Surg 133:929–935CrossRefPubMed
23.
go back to reference Suryanarayanan R, Cook JA (2004) Long-term results of gentamicin inner ear perfusion in Ménière’s disease. J Laryngol Otol 118(7):489–495CrossRefPubMed Suryanarayanan R, Cook JA (2004) Long-term results of gentamicin inner ear perfusion in Ménière’s disease. J Laryngol Otol 118(7):489–495CrossRefPubMed
24.
go back to reference Seidman M (2002) Continuous gentamicin therapy using an IntraEAR microcatheter for Ménière’s disease: a retrospective study. Otolaryngol Head Neck Surg 126:244–256CrossRefPubMed Seidman M (2002) Continuous gentamicin therapy using an IntraEAR microcatheter for Ménière’s disease: a retrospective study. Otolaryngol Head Neck Surg 126:244–256CrossRefPubMed
25.
go back to reference Hoffer ME, Kopke RD, Weisskopf P, Gottshall K, Allen K, Wester D (2001) Microdose gentamicin administration via the round window microcatheter: results in patients with Meniere’s disease. Ann N Y Acad Sci 942:46–51CrossRefPubMed Hoffer ME, Kopke RD, Weisskopf P, Gottshall K, Allen K, Wester D (2001) Microdose gentamicin administration via the round window microcatheter: results in patients with Meniere’s disease. Ann N Y Acad Sci 942:46–51CrossRefPubMed
26.
go back to reference Schoendorf J, Neugebauer P, Michel O (2001) Continuous intratympanic infusion of gentamicin via a microcatheter in Menière’s disease. Otolaryngol Head Neck Surg 124(2):203–207CrossRefPubMed Schoendorf J, Neugebauer P, Michel O (2001) Continuous intratympanic infusion of gentamicin via a microcatheter in Menière’s disease. Otolaryngol Head Neck Surg 124(2):203–207CrossRefPubMed
27.
go back to reference Charabi S, Thomsen J, Tos M (2000) Round Window Gentamicin m-Catheter—a New therapeutic tool in Meniere’s disease. Acta Otolaryngol Suppl 543:108–110CrossRefPubMed Charabi S, Thomsen J, Tos M (2000) Round Window Gentamicin m-Catheter—a New therapeutic tool in Meniere’s disease. Acta Otolaryngol Suppl 543:108–110CrossRefPubMed
28.
go back to reference Silverstein H, Arruda J, Rosenberg SI, Deems D, Hester TO (1999) Direct round window membrane application of gentamicin in the treatment of Meniere’s disease. Otolaryngol Head Neck Surg 120:649–655CrossRefPubMed Silverstein H, Arruda J, Rosenberg SI, Deems D, Hester TO (1999) Direct round window membrane application of gentamicin in the treatment of Meniere’s disease. Otolaryngol Head Neck Surg 120:649–655CrossRefPubMed
29.
go back to reference DeCicco MJ, Hoffer ME, Kopke RD et al (1998) Round-window microcatheter administered microdose gentamicin: results from treatment of tinnitus associated with Ménière’s disease. Int Tinnitus J. 4:141–143PubMed DeCicco MJ, Hoffer ME, Kopke RD et al (1998) Round-window microcatheter administered microdose gentamicin: results from treatment of tinnitus associated with Ménière’s disease. Int Tinnitus J. 4:141–143PubMed
30.
go back to reference Barany R (1935) Die Beinflussung des Ohrensausens durch intravenose injizierte lokalanaesthetica. Acta Otolaryngol 23:201–207CrossRef Barany R (1935) Die Beinflussung des Ohrensausens durch intravenose injizierte lokalanaesthetica. Acta Otolaryngol 23:201–207CrossRef
31.
go back to reference Schuknecht HF (1950) Ablation therapy for the relief of Ménière’s disease. Laryngoscope 66:859–871CrossRef Schuknecht HF (1950) Ablation therapy for the relief of Ménière’s disease. Laryngoscope 66:859–871CrossRef
32.
go back to reference Sakata E, Kitago Y, Murato Y, Teramoto K (1986) Treatment of Ménière’s disease. Middle ear infusion with lidocaine and steroid solution. Auris Nasus Larynx 13:79–89CrossRefPubMed Sakata E, Kitago Y, Murato Y, Teramoto K (1986) Treatment of Ménière’s disease. Middle ear infusion with lidocaine and steroid solution. Auris Nasus Larynx 13:79–89CrossRefPubMed
33.
go back to reference Chandrasekhar SS, Rubinstein RY, Kwartler JA et al (2000) Dexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents. Otolaryngol Head Neck Surg 122(4):521–528PubMed Chandrasekhar SS, Rubinstein RY, Kwartler JA et al (2000) Dexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents. Otolaryngol Head Neck Surg 122(4):521–528PubMed
34.
go back to reference Parnes LS, Sun AH, Freeman DJ (1999) Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 109(7 Pt 2):1–17CrossRefPubMed Parnes LS, Sun AH, Freeman DJ (1999) Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 109(7 Pt 2):1–17CrossRefPubMed
35.
go back to reference Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Ménière’s disease (1995) Otolaryngol Head Neck Surg 113:181–185 Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Ménière’s disease (1995) Otolaryngol Head Neck Surg 113:181–185
36.
go back to reference Weisskopf P, Hoffer ME, Kopke RD et al (2001) Microdose gentamicin delivered via the round window microcatheter: a therapeutic option in Meniere’s disease: operative techniques. Otolaryngol Head Neck Surg 12:154–156 Weisskopf P, Hoffer ME, Kopke RD et al (2001) Microdose gentamicin delivered via the round window microcatheter: a therapeutic option in Meniere’s disease: operative techniques. Otolaryngol Head Neck Surg 12:154–156
Metadata
Title
Is gentamycin delivery via sustained-release vehicles a safe and effective treatment for refractory Meniere’s disease? A critical analysis of published interventional studies
Authors
Petros V. Vlastarakos
Emily Iacovou
Thomas P. Nikolopoulos
Publication date
01-03-2017
Publisher
Springer Berlin Heidelberg
Published in
European Archives of Oto-Rhino-Laryngology / Issue 3/2017
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-016-4294-9

Other articles of this Issue 3/2017

European Archives of Oto-Rhino-Laryngology 3/2017 Go to the issue